Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy

G. Jerusalem, S. Farah, A. Courtois, J. Chirgwin, S. Aebi, P. Karlsson, P. Neven, E. Hitre, M.P. Graas, E. Simoncini, E. Abdi, C. Kamby, A. Thompson, S. Loibl, J. Gavilá, K. Kuroi, C. Marth, B. Müller, S. O'Reilly, A. GombosT. Ruhstaller, H.J. Burstein, M. Rabaglio, B. Ruepp, K. Ribi, G. Viale, R.D. Gelber, A.S. Coates, S. Loi, A. Goldhirsch, M.M. Regan, M. Colleoni

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1256-1266
Number of pages11
JournalAnnals of Oncology
Volume32
Issue number10
Publication statusPublished - 2021

Cite this